Literature DB >> 19120904

Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease.

Hiroaki Nema1, Mototsugu Kato, Takehiko Katsurada, Youichi Nozaki, Akihiko Yotsukura, Izumi Yoshida, Katsuhiko Sato, Yuko Kawai, Yasushi Takagi, Takanori Okusa, Shunichi Takiguchi, Masayuki Sakurai, Masahiro Asaka.   

Abstract

BACKGROUND AND AIM: Low-dose aspirin is effective for the prevention of cardiovascular and cerebrovascular events, but the frequency of gastrointestinal injuries among users of low-dose aspirin in Japan is currently unknown. In the present study endoscopic examination was performed to investigate the frequency of gastroduodenal injuries associated with low-dose aspirin in patients with ischemic heart disease (IHD).
METHODS: Screening upper endoscopic examinations were prospectively performed on 131 patients with IHD who were not receiving antiulcer treatment. Endoscopic findings such as ulcers and flat erosions were assessed as mucosal injuries.
RESULTS: Mucosal injuries were found in 62 of 101 (61.4%) low-dose aspirin users and three of 30 (10%) nonaspirin users. There were significantly more mucosal injuries among low-dose aspirin users than among the non-users (P<0.0001). Gastroduodenal ulcers were found in 19 of 101 (18.8%) low-dose aspirin users compared with one of 30 (3.3%) nonaspirin users. The frequency of mucosal injuries was not associated with the duration of aspirin treatment.
CONCLUSION: Endoscopy frequently reveals low-dose aspirin-induced gastroduodenal injuries in patients with IHD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120904     DOI: 10.1111/j.1440-1746.2008.05411.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Factors associated with the initiation of proton pump inhibitors in corticosteroid users.

Authors:  Jeffrey C Munson; Peter M Wahl; Gregory Daniel; Stephen E Kimmel; Sean Hennessy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01-25       Impact factor: 2.890

2.  A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.

Authors:  Nobuyuki Sugisaki; Ryuichi Iwakiri; Nanae Tsuruoka; Yasuhisa Sakata; Ryo Shimoda; Shun Fujimoto; Yuichiro Eguchi; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2018-06-12       Impact factor: 7.527

Review 3.  Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.

Authors:  Junichi Iwamoto; Yoshifumi Saito; Akira Honda; Yasushi Matsuzaki
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

4.  The role of trefoil factor family in apparently healthy subjects administrated gastroprotective agents for the primary prevention of gastrointestinal injuries from low-dose acetylsalicylic acid: a preliminary study.

Authors:  Takashi Kawai; Yu Takagi; Mari Fukuzawa; Tetsuya Yamagishi; Shinya Goto
Journal:  J Clin Biochem Nutr       Date:  2011-08-25       Impact factor: 3.114

5.  Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial.

Authors:  Mitsuhiro Fujishiro; Kazuhide Higuchi; Mototsugu Kato; Yoshikazu Kinoshita; Ryuichi Iwakiri; Toshio Watanabe; Toshihisa Takeuchi; Nobuyuki Sugisaki; Yasushi Okada; Hisao Ogawa; Tetsuo Arakawa; Kazuma Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2015-04-08       Impact factor: 3.114

6.  Are the Symptoms of an NSAID-Induced Ulcer Truly Milder Than Those of an Ordinary Ulcer?

Authors:  Toshihiko Tomita; Sumire Mori; Katsuyuki Tozawa; Eitatsu Arai; Nobuo Tano; Hideo Oka; Yongmin Kim; Takashi Abe; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  Gastroenterol Res Pract       Date:  2017-08-27       Impact factor: 2.260

7.  Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.

Authors:  Naomi Uemura; Kentaro Sugano; Hideyuki Hiraishi; Kazuyuki Shimada; Shinya Goto; Shinichiro Uchiyama; Yasushi Okada; Hideki Origasa; Yasuo Ikeda
Journal:  J Gastroenterol       Date:  2013-06-12       Impact factor: 7.527

8.  Clinical Risk Factors for Gastroduodenal Ulcer in Romanian Low-Dose Aspirin Consumers.

Authors:  Anca Negovan; Mihaela Iancu; Valeriu Moldovan; Septimiu Voidazan; Simona Bataga; Monica Pantea; Kinga Sarkany; Cristina Tatar; Simona Mocan; Claudia Banescu
Journal:  Gastroenterol Res Pract       Date:  2016-08-08       Impact factor: 2.260

9.  Prasugrel effectively reduces the platelet reactivity units in patients with genetically metabolic dysfunction of cytochrome P450 2C19 who are treated with long-term dual antiplatelet therapy after undergoing drug-eluting stent implantation.

Authors:  Junichiro Shimamatsu; Ken-Ichiro Sasaki; Yoshio Katsuki; Tomohiro Kawasaki; Yoshinobu Murasato; Hidehiko Ajisaka; Hiroyoshi Yokoi; Hideki Tashiro; Atsushi Harada; Yuji Hirakawa; Yuta Ishizaki; Takashi Ishimatsu; Kotaro Kagiyama; Yoshihiro Fukumoto; Tatsuyuki Kakuma; Takafumi Ueno
Journal:  Heart Vessels       Date:  2019-09-23       Impact factor: 2.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.